Yonsei University
๐ฐ๐ทSouth Korea
- Country
- ๐ฐ๐ทSouth Korea
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.yonsei.ac.kr
Evaluation of Liver Fibrosis Staging With Acoustic Radiation Force Impulse Elastography
Completed
- Conditions
- Chronic Liver Disease
- Interventions
- Device: Acoustic radiation force impulse imaging
- First Posted Date
- 2011-01-25
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 150
- Registration Number
- NCT01283230
- Locations
- ๐ฐ๐ท
Severance Hospital, Seoul, Korea, Republic of
Study of PIVKA-II and AFP Measurement in Surveillance Program for Early Detection of Hepatocellular Carcinoma
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Device: tumor maker interval shortly
- First Posted Date
- 2011-01-17
- Last Posted Date
- 2011-01-17
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 1000
- Registration Number
- NCT01277653
- Locations
- ๐ฐ๐ท
Severance Hospital, Seoul, Seodaemun-gu, Korea, Republic of
Investigatory Study of Metformin's Pharmacokinetics, Pharmacodynamics and Drug Drug Interactions Classifying the Group by MATE1 Genotype in Healthy Volunteers
- First Posted Date
- 2011-01-11
- Last Posted Date
- 2012-05-11
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 30
- Registration Number
- NCT01274130
- Locations
- ๐ฐ๐ท
Severance Hospital, Seoul, Korea, Republic of
The Effect of Pressure Controlled Ventilation on the Pulmonary Mechanics in Prone Position Using the Wilson Frame: A Comparison With Volume Controlled Ventilation
Not Applicable
Completed
- Conditions
- Herniation of Lumbar Vertebral Disc
- Interventions
- Procedure: pressure controlProcedure: volume control
- First Posted Date
- 2011-01-10
- Last Posted Date
- 2012-02-03
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 40
- Registration Number
- NCT01272700
- Locations
- ๐ฐ๐ท
Severance Hospital, Seoul, Korea, Republic of
Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B
Phase 3
- Conditions
- Chronic Hepatitis B
- First Posted Date
- 2011-01-05
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 110
- Registration Number
- NCT01270165
- Locations
- ๐ฐ๐ท
Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of
A Trial of Induction Chemotherapy and Chemoradiotherapy With TS-1 and Cisplatin (SP) as First-line Treatment in Patients With High Risk Advanced Gastric Cancer
- First Posted Date
- 2011-01-04
- Last Posted Date
- 2013-06-04
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 6
- Registration Number
- NCT01269255
- Locations
- ๐ฐ๐ท
Severance Hospital, Seoul, Korea, Republic of
A Trial of Neoadjuvant FOLFOX6 With Short Course Radiotherapy in Patients With Unresectable Rectal Cancer and Liver Metastasis
Phase 2
Completed
- Conditions
- Rectal Cancer
- First Posted Date
- 2011-01-04
- Last Posted Date
- 2016-09-07
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 32
- Registration Number
- NCT01269229
- Locations
- ๐ฐ๐ท
Severance Hospital, Seoul, Korea, Republic of
Characterization and Evaluation of Diagnostic Biomarkers for Tuberculosis
Completed
- Conditions
- Active Tuberculosis
- First Posted Date
- 2011-01-04
- Last Posted Date
- 2019-03-18
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 270
- Registration Number
- NCT01269268
- Locations
- ๐ฐ๐ท
Severance Hospital, Seoul, Korea, Republic of
A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer
Phase 2
Completed
- Conditions
- Rectal Cancer
- Interventions
- Drug: TS-1 with Irinotecan
- First Posted Date
- 2011-01-04
- Last Posted Date
- 2015-01-28
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 136
- Registration Number
- NCT01269216
- Locations
- ๐ฐ๐ท
Severance Hospital, Seoul, Korea, Republic of
Sequential High-dose Dexamethasone and Response Adopted PAD or VAD Induction Chemotherapy Followed by High-dose Chemotherapy With Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Phase 2
Completed
- Conditions
- Multiple Myeloma
- Interventions
- Drug: high dose dexamethsone
- First Posted Date
- 2010-12-07
- Last Posted Date
- 2017-11-28
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 30
- Registration Number
- NCT01255514
- Locations
- ๐ฐ๐ท
Seoul St. Mary's Hospital, Seoul, Korea, Republic of
๐ฐ๐ทChonnam National University Hwasun Hospital, Hwasun, Korea, Republic of
๐ฐ๐ทNational Cancer Center, Goyang, Korea, Republic of
ยฉ Copyright 2025. All Rights Reserved by MedPath